Active Management for Low Back Pain for 6 to 8 Year Old Schoolchildren
The objective is to assess the effectiveness of a prevention campaign promoting active management in shifting beliefs in 6 to 8 year old schoolchildren. Subjects will be taken from a random sample of schools in Majorca, Spain: private, public and concerted. A 10 item questionnaire will be given to all children in that age group, to be answered in class on days 1, 14 and 97. Schools will be randomly assigned to the study and control groups. In the study group the students will get a Back Comic-Book (promotes active management) after the first assessment. The control group will have no other intervention than the questionnaire.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Prevention
|Official Title:||Active Management for Low Back Pain Taught to 6 to 8 Year Old Schoolchildren|
- Assessment of the effectiveness of a prevention campaign promoting active management of low back pain in shifting beliefs in 6 to 8 year old schoolchildren. [ Time Frame: 4 months ] [ Designated as safety issue: No ]
- Assessment of the effectiveness of a prevention campaign promoting active management on low back pain in 6 to 8 year old schoolchildren. [ Time Frame: 4 months ] [ Designated as safety issue: No ]
|Study Start Date:||February 2009|
|Study Completion Date:||June 2009|
|Primary Completion Date:||May 2009 (Final data collection date for primary outcome measure)|
Active Comparator: 1
The intervention group will receive prevention of low back pain education through a Back Comic-Book, and their beliefs/knowledge will be tested twice after intervention.
Behavioral: Education (Back Comic-Book)
Through the Back Comic-Book the schoolchildren are taught prevention methods for low back pain.
No Intervention: 2
The control group will receive no intervention, and their beliefs/knowledge on low back pain will be tested twice after the first assessment.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00809640
|Palma de Mallorca, Balearic Islands, Spain, 07012|
|Study Director:||Francisco M Kovacs, MD, PhD||Kovacs Foundation, Palma de Mallorca, 07012, Spain|
|Principal Investigator:||Mario Gestoso, MD||Kovacs Foundation,Palma de Mallorca, Spain|